Hospice News March 20, 2025
A proposed rule by the U.S. Drug Enforcement Administration (DEA) could impede timely access to medications for hospice and palliative care patients, according to members of the hospice community.
The DEA proposed a rule in the final days of the Biden administration that could change the game for prescribing controlled substances via telehealth, including some common hospice medications. If finalized, this proposed rule would require prescribers to register with the DEA before they are allowed to prescribe schedule II-V controlled substances, along with some monitoring and other requirements.
“DEA’s goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market,” said former DEA Administrator Anne Milgram, in...
Today's Sponsors
Today's Sponsor